Nauru vs North Macedonia: The number of people with susceptibility test result for rifampicin
Nauru
100
in 2021
North Macedonia
100
in 2021
Nauru rank
2nd
North Macedonia rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Nauru
- North Macedonia
How they compare
Nauru currently reports 100 against 100 in North Macedonia, a difference of 0.
Across all 5 years both countries report, North Macedonia has been ahead every year.
Nauru ranks 2nd and North Macedonia ranks 2nd of 146 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nauru | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0 | 98.27 | 98.27 | North Macedonia |
| 2020s | 50 | 92.63 | 42.63 | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nauru or North Macedonia?
- Nauru, at 100 against 100 in North Macedonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nauru and North Macedonia?
- 0, with Nauru ahead.
- How many years of comparable data are there for Nauru and North Macedonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Nauru and North Macedonia rank globally for the number of people with susceptibility test result for rifampicin?
- Nauru ranks 2nd and North Macedonia ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.